OLORINAB

UNII:	581F7DFA9B
Formula:	C₁₈H₂₃N₅O₃
Preferred Substance Name:	OLORINAB
InChIKey:	ACSQLTBPYZSGBA-GMXVVIOVSA-N

1268881-20-4
(1AS,5AS)-2-(4-OXY-PYRAZIN-2-YL)-1A,2,5,5A-TETRAHYDRO-1H-2,3-DIAZA-CYCLOPROPA(A)PENTALENE-4-CARBOXYLIC ACID ((S)-1-HYDROXYMETHYL-2,2-DIMETHYL-PROPYL)-AMIDE
(4AS,5AS)-N-((2S)-1-HYDROXY-3,3-DIMETHYLBUTAN-2-YL)-1-(4-OXIDOPYRAZIN-2-YL)-4,4A,5,5A-TETRAHYDRO-1H-CYCLOPROPA(4,5)CYCLOPENTA(1,2-C)PYRAZOLE-3-CARBOXAMIDE
1H-CYCLOPROPA(4,5)CYCLOPENTA(1,2-C)PYRAZOLE-3-CARBOXAMIDE, 4,4A,5,5A-TETRAHYDRO-N-((1S)-1-(HYDROXYMETHYL)-2,2-DIMETHYLPROPYL)-1-(4-OXIDO-2-PYRAZINYL)-, (4AS,5AS)-
APD371
APD-371
OLORINAB [INN]
OLORINAB [USAN]
OLORINAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

OLORINAB

Synonyms and Mappings

Resources